(Q37892600)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692708%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

review article

1 reference

title

Colorectal cancer vaccines in clinical trials (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692708%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692708%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Cornelis J. M. Melief

4

object named as

Cornelis J M Melief

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692708%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Sjoerd H van der Burg

5

object named as

Sjoerd H van der Burg

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692708%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

Frank M Speetjens

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692708%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Eliane C M Zeestraten

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692708%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

publication date

1 June 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692708%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Vaccines

5 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692708%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692708%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692708%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

899-921

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692708%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

cites work

Cancer statistics, 2010

1 reference

Worldwide variations in colorectal cancer

21 January 2018

1 reference

Systemic therapy for colorectal cancer

21 January 2018

1 reference

Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial.

21 January 2018

1 reference

Evolution of nonsurgical therapy for colorectal cancer

21 January 2018

1 reference

Cancer: a biological approach. III. Viruses associated with neoplastic conditions. IV. Practical applications.

21 January 2018

1 reference

Effects of chronic immunosuppression on long-term oncologic outcomes for colorectal cancer patients undergoing surgery.

21 January 2018

1 reference

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

21 January 2018

1 reference

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

21 January 2018

1 reference

Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer

21 January 2018

1 reference

Sipuleucel-T: in metastatic castration-resistant prostate cancer

21 January 2018

1 reference

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

21 January 2018

1 reference

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

21 January 2018

1 reference

Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens

21 January 2018

1 reference

Adoptive cell transfer: a clinical path to effective cancer immunotherapy

21 January 2018

1 reference

Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia

21 January 2018

1 reference

Cancer despite immunosurveillance: immunoselection and immunosubversion

21 January 2018

1 reference

CD20+ B cells: the other tumor-infiltrating lymphocytes

21 January 2018

1 reference

Immunotherapy with autologous tumor cell-BCG vaccine in patients with colon cancer: a prospective study of medical and economic benefits

21 January 2018

1 reference

Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial

21 January 2018

1 reference

A phase II study of active specific immunotherapy and 5-FU/Leucovorin as adjuvant therapy for stage III colon carcinoma

21 January 2018

1 reference

Adjuvant active specific immunotherapy for stage II and III colon cancer with an autologous tumor cell vaccine: Eastern Cooperative Oncology Group Study E5283.

21 January 2018

1 reference

Adjuvant active specific immunotherapy for human colorectal cancer: 6.5-year median follow-up of a phase III prospectively randomized trial

21 January 2018

1 reference

Efficiency of adjuvant active specific immunization with Newcastle disease virus modified tumor cells in colorectal cancer patients following resection of liver metastases: results of a prospective randomized trial

21 January 2018

1 reference

Application of autologous tumor cell vaccine and NDV vaccine in treatment of tumors of digestive tract

21 January 2018

1 reference

Regulating functional cell fates in CD8 T cells

21 January 2018

1 reference

Clinical Benefit of Allogeneic Melanoma Cell Lysate-Pulsed Autologous Dendritic Cell Vaccine in MAGE-Positive Colorectal Cancer Patients.

21 January 2018

1 reference

Molecular and immunological evaluation of the expression of cancer/testis gene products in human colorectal cancer.

21 January 2018

1 reference

Expression of melanoma antigen-encoding genes (MAGE) by common primers for MAGE-A1 to -A6 in colorectal carcinomas among Koreans

21 January 2018

1 reference

Part I: Vaccines for solid tumours

21 January 2018

1 reference

Immunology and immunotherapy of colorectal cancer

21 January 2018

1 reference

5T4-modified vaccinia Ankara: progress in tumor-associated antigen-based immunotherapy

21 January 2018

1 reference

21 January 2018

1 reference

The use of HLA A2.1/p53 peptide tetramers to visualize the impact of self tolerance on the TCR repertoire

21 January 2018

1 reference

Targeting of antigens to B cells augments antigen-specific T-cell responses and breaks immune tolerance to tumor-associated antigen MUC1

21 January 2018

1 reference

Tumor-associated MUC1 glycopeptide epitopes are not subject to self-tolerance and improve responses to MUC1 peptide epitopes in MUC1 transgenic mice

21 January 2018

1 reference

Effective therapeutic anticancer vaccines based on precision guiding of cytolytic T lymphocytes.

21 January 2018

1 reference

Immunotherapy of established (pre)malignant disease by synthetic long peptide vaccines

21 January 2018

1 reference

Phase I/II combined chemoimmunotherapy with carcinoembryonic antigen-derived HLA-A2-restricted CAP-1 peptide and irinotecan, 5-fluorouracil, and leucovorin in patients with primary metastatic colorectal cancer

21 January 2018

1 reference

Immunological evaluation of personalized peptide vaccination in combination with UFT and UZEL for metastatic colorectal carcinoma patients.

21 January 2018

1 reference

A phase I trial of cytotoxic T-lymphocyte precursor-oriented peptide vaccines for colorectal carcinoma patients

21 January 2018

1 reference

Vaccination of metastatic colorectal cancer patients with matured dendritic cells loaded with multiple major histocompatibility complex class I peptides

21 January 2018

1 reference

Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy

21 January 2018

1 reference

Immunotherapy with Autologous, Human Dendritic Cells Transfected with Carcinoembryonic Antigen mRNA

21 January 2018

1 reference

Combination chemotherapy and ALVAC-CEA/B7.1 vaccine in patients with metastatic colorectal cancer

21 January 2018

1 reference

Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule

21 January 2018

1 reference

Safety of intravenous administration of a canarypox virus encoding the human wild-type p53 gene in colorectal cancer patients

21 January 2018

1 reference

Vaccination of colorectal cancer patients with modified vaccinia Ankara delivering the tumor antigen 5T4 (TroVax) induces immune responses which correlate with disease control: a phase I/II trial

21 January 2018

1 reference

Vaccination of colorectal cancer patients with modified vaccinia ankara encoding the tumor antigen 5T4 (TroVax) given alongside chemotherapy induces potent immune responses.

21 January 2018

1 reference

Immune evasion mechanisms in colorectal cancer liver metastasis patients vaccinated with TroVax (MVA-5T4).

21 January 2018

1 reference

Combination of active specific immunotherapy or adoptive antibody or lymphocyte immunotherapy with chemotherapy in the treatment of cancer

21 January 2018

1 reference

Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates

21 January 2018

1 reference

Immunization with a P53 synthetic long peptide vaccine induces P53-specific immune responses in ovarian cancer patients, a phase II trial

21 January 2018

1 reference

Immunization with a HER-2/neu helper peptide vaccine generates HER-2/neu CD8 T-cell immunity in cancer patients

21 January 2018

1 reference

Tumor antigen-specific T helper cells in cancer immunity and immunotherapy

21 January 2018

1 reference

CD8(+) T cell responses against a dominant cryptic HLA-A2 epitope after NY-ESO-1 peptide immunization of cancer patients

21 January 2018

1 reference

Detection and functional analysis of tumor infiltrating T-lymphocytes (TIL) in liver metastases from colorectal cancer.

21 January 2018

1 reference

Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer

21 January 2018

1 reference

Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer).

21 January 2018

1 reference

Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis

21 January 2018

1 reference

Microsatellite instability in cancer of the proximal colon

21 January 2018

1 reference

Microsatellite instability in ovarian neoplasms

21 January 2018

1 reference

Genetic instabilities in human cancers

21 January 2018

1 reference

Different mechanisms in the tumorigenesis of proximal and distal colon cancers

21 January 2018

1 reference

Prediction of the immunogenic potential of frameshift-mutated antigens in microsatellite instable cancer

21 January 2018

1 reference

Immune response against frameshift-induced neopeptides in HNPCC patients and healthy HNPCC mutation carriers

21 January 2018

1 reference

Success or failure of vaccination for HPV16-positive vulvar lesions correlates with kinetics and phenotype of induced T-cell responses

21 January 2018

1 reference

Tumor-specific regulatory T cells in cancer patients

21 January 2018

1 reference

Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines.

21 January 2018

1 reference

Magnitude and polarization of P53-specific T-helper immunity in connection to leukocyte infiltration of colorectal tumors.

21 January 2018

1 reference

Immune surveillance of tumors

21 January 2018

1 reference

Coordination of intratumoral immune reaction and human colorectal cancer recurrence.

21 January 2018

1 reference

CD8(+) T lymphocyte mobilization to virus-infected tissue requires CD4(+) T-cell help

21 January 2018

1 reference

CD4+ T-cell help in the tumor milieu is required for recruitment and cytolytic function of CD8+ T lymphocytes

21 January 2018

1 reference

Disrupted expression of CXCL5 in colorectal cancer is associated with rapid tumor formation in rats and poor prognosis in patients.

21 January 2018

1 reference

Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy.

21 January 2018

1 reference

Biomolecular Network Reconstruction Identifies T-Cell Homing Factors Associated With Survival in Colorectal Cancer

21 January 2018

1 reference

Improved Endpoints for Cancer Immunotherapy Trials

21 January 2018

1 reference

Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI)

21 January 2018

1 reference

Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine Consortium

21 January 2018

1 reference

Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria

21 January 2018

1 reference

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

21 January 2018

1 reference

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

New response criteria proposed for immunotherapies

21 January 2018

1 reference

Changes in cytokine and biomarker blood levels in patients with colorectal cancer during dendritic cell-based vaccination

21 January 2018

1 reference

A listing of human tumor antigens recognized by T cells: March 2004 update

21 January 2018

1 reference

Cancer risk after renal transplantation in the nordic countries, 1964-1986

21 January 2018

1 reference

Vaccination of colorectal cancer patients with CEA-loaded dendritic cells: antigen-specific T cell responses in DTH skin tests

21 January 2018

1 reference

Dendritic Cell Vaccination in Combination with Anti-CD25 Monoclonal Antibody Treatment: A Phase I/II Study in Metastatic Melanoma Patients

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERV.11.63

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692708%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference